APRIL ARANDA: Open Payments
NPI 1346023090 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 56 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,432 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $220 |
| ABBVIE INC. | 15 | $207 |
| Janssen Pharmaceuticals, Inc | 6 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $168 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Noven Therapeutics, LLC | 4 | $60 |
| Alkermes, Inc. | 2 | $52 |
| Corium, LLC | 2 | $33 |
| Indivior Inc. | 1 | $29 |
| Tris Pharma Inc | 1 | $23 |
Products named: VRAYLAR, SPRAVATO, REXULTI, CAPLYTA, FANAPT, Xelstrym, VIVITROL, Azstarys.
Industry payments across AZ — which companies pay providers there.
